Using estimates for the anthelmintic efficacy of a single nose of ivermecti
n in the treatment of lymphatic filariasis patients Anton Plaisier, Wilma S
tolk, Gerrit van Oortmarssen and Dik Habbema here present and discuss model
predictions of the impact of a five-year programme of annual community tre
atment on the intensity of infection. They show that the effectiveness of s
uch programmes in terms of reductions in the microfilarial density depends
critically on the treatment coverage and the pattern of attendance at repea
ted mass administrations. Improving these factors will possibly be more imp
ortant than improving the efficacy of ivermectin by increasing its dosage o
r by adding other drugs.